SCM
ZYME icon

Soleus Capital Management’s Zymeworks ZYME Stock Holding History

Soleus Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-327,900
Closed -$11.8M – 75
2020
Q2 		$11.8M Buy
+327,900
New +$12.1M 6.74% 3

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Soleus Capital Management's ZYME Position: Q1 2026 in Review

Soleus Capital Management reduced its Zymeworks (ZYME) stake by 90% in Q1 2026, selling an estimated $2.13M and leaving 10,000 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #90.

Soleus Capital Management first reported a position in ZYME in Q4 2019 and has held it in 7 quarters since. The position peaked at $15.2M in Q2 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Soleus Capital Management held 10,000 shares of Zymeworks worth $250K as of Q1 2026.
  • Soleus Capital Management sold 90,000 Zymeworks shares in Q1 2026, an estimated $2.13M.
  • Zymeworks made up 0.01% of Soleus Capital Management's portfolio in Q1 2026, its #90 holding.
  • Soleus Capital Management first reported a position in Zymeworks in Q4 2019 and has held it in 7 quarters since.
  • Soleus Capital Management's Zymeworks position peaked at $15.2M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.